Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
06/2002
06/20/2002WO2002048114A1 Phenylacetamido- pyrazole derivatives and their use as antitumor agents
06/20/2002WO2002048112A2 7-heterocyclyl quinoline and thieno[2,3-b]pyridine derivatives useful as antagonists of gonadotropin releasing hormone
06/20/2002WO2002048110A2 Composition for regulating animal growth, method of manufacture and use thereof
06/20/2002WO2002048107A1 Antitumoral carbazoles
06/20/2002WO2002048106A2 Isoindolin-1-one glucokinase activators
06/20/2002WO2002048099A1 Carboxylic acid amide derivatives and their use in the treatment of thromboembolic diseases and tumours
06/20/2002WO2002048096A1 Hydrazone derivatives and use thereof in medicines
06/20/2002WO2002047762A1 Serine protease inhibitors
06/20/2002WO2002047731A2 Drug delivery compositions and coated medical devices
06/20/2002WO2002047730A2 Intracellular delivery of charged therapeutic moieties to nerve cells by means of targeting proteins
06/20/2002WO2002047726A2 Pharmaceutical composition containing an active with a hemolytic action and a surfactant
06/20/2002WO2002047725A2 Pharmaceutical oxaliplatinum preparation for parenteral administration and method for obtaining same
06/20/2002WO2002047723A1 Medicinal compositions having improved water-solubility
06/20/2002WO2002047722A1 Medicinal compositions of nonpeptidyl gonadotropin-releasing hormone agonist or antagonist, process for producing the same and use thereof
06/20/2002WO2002047703A2 Immune system stimulation
06/20/2002WO2002047701A1 Composition comprising melissa leaf extract for anti-angiogenic and matrix metalloproteinase inhibitory activity
06/20/2002WO2002047696A1 Use of low molecular heparin for treating osteoarthritis
06/20/2002WO2002047695A1 Blocking the adsorption of germs in birds
06/20/2002WO2002047694A1 Pharmaceutical compositions for treatment of digestive disorders and associated diseases
06/20/2002WO2002047693A2 Steroid hormone products comprising a stabilizing agent in non-crystalline form
06/20/2002WO2002047692A1 Use of an oestrogen in the manufacture of a composition containing oestrogen for the treatment of atrophic vaginitis
06/20/2002WO2002047691A1 Protection of neurons against glutamate-induced damage in glaucoma and other conditions
06/20/2002WO2002047690A1 Substituted 2-aryl-4-arylaminopyrimidines and analogs as activators of caspases and inducers of apoptosis and the use thereof
06/20/2002WO2002047689A2 Use of cetirizine or efletirizine for preventing urticaria
06/20/2002WO2002047688A2 Method and apparatus for treating breakthrough pain
06/20/2002WO2002047687A1 Urotensin-ii receptor antagonists
06/20/2002WO2002047686A1 Substituted-4-quinolones
06/20/2002WO2002047685A2 Nmda receptor agonist pharmaceutical compositions
06/20/2002WO2002047684A1 Methof for treatment of female sexual dysfunction
06/20/2002WO2002047683A1 Blood lipid ameliorant composition
06/20/2002WO2002047682A1 Blood lipid ameliorant composition
06/20/2002WO2002047681A1 Regulation of bacterial virulence
06/20/2002WO2002047680A2 Use of tocopherol, metabolites or derivatives thereof or flavonoid metabolites or derivatives thereof in the manufacture of a medicament for the treatment of tissue ischemia
06/20/2002WO2002047678A1 Antilipemic agents
06/20/2002WO2002047677A1 Agents for ameliorating carbonyl stress
06/20/2002WO2002047676A1 Topical composition and method for treating urinary stress incontinence
06/20/2002WO2002047675A1 Novel use of diterpene compound as a therapeutic agent of inflammation, immune disease or cancer
06/20/2002WO2002047674A2 Use of intracellular calcium chelators (e.g bapta-am) to increase surfactant secretion in the lungs
06/20/2002WO2002047673A2 Methods and compositions to treat conditions associated with neovascularization
06/20/2002WO2002047672A2 Treatment of cystic fibrosis with alkalinizing agents
06/20/2002WO2002047671A2 Lactam compound to inhibit beta-amyloid peptide release or synthesis
06/20/2002WO2002047670A1 Treatment of male sexual dysfunction
06/20/2002WO2002047669A1 Use of ep4 receptor agonists for treating neuropathic pain
06/20/2002WO2002047668A2 Novel medicament compositions based on anticholinesterase drugs and on ciclesonides
06/20/2002WO2002047667A2 Novel medicament compositions based on anticholinesterase drugs and on a steroid
06/20/2002WO2002047666A1 Use of a dopamine agonist with a short half-life for treating illnesses which can be treated by dopaminergic means
06/20/2002WO2002047663A1 Self emulsifying lipid matrix (selm)
06/20/2002WO2002047662A2 Antibiotic/benzoyl peroxide dispenser
06/20/2002WO2002047661A1 Pharmaceutical composition for intramuscular injection containing loxoprofen
06/20/2002WO2002047660A1 Pharmaceutical dronedarone composition for parenteral administration
06/20/2002WO2002047649A1 Composition containing 7-hydroxy dhea and/or 7-keto dhea and at least a carotenoid
06/20/2002WO2002047643A1 Water-free skin care formulations comprising micronized urea and method of manufacturing the same
06/20/2002WO2002047642A1 Hypoallergenic and non-irritant skin care formulations
06/20/2002WO2002047631A1 Composition, in particular cosmetic, containing 7-hydroxy dhea and/or 7-keto dhea and at least an isoflavonoid
06/20/2002WO2002047615A2 Oral compositions and use thereof
06/20/2002WO2002047611A2 Cddo-compounds and combination therapies thereof
06/20/2002WO2002047604A2 Novel use of chalcone class compounds for inhibiting tumoral mass vascularization
06/20/2002WO2002047603A2 Use of levosimendan for treating erictile dysfunction
06/20/2002WO2002047534A2 Compositions and methods for the therapy and diagnosis of lung cancer
06/20/2002WO2002047493A2 Health promoting compositions
06/20/2002WO2002047456A2 Urotensin-ii receptor antagonists
06/20/2002WO2002034276A3 Use of the association of at least a plant extract of the genus camellia and of at least a carotenoid
06/20/2002WO2002030894A3 Compositions and methods of the use thereof achiral analogues of cc-1065 and the duocarmycins
06/20/2002WO2002030888A3 Tricyclic compounds and uses thereof
06/20/2002WO2002028406A3 Induction of blood vessel formation by polynucleotides encoding sphingosine kinases
06/20/2002WO2002026759A3 17α FLUOROALKYL STEROIDS, METHOD FOR PRODUCING THE SAME AND PHARMACEUTICAL COMPOSITIONS CONTAINING SAID COMPOUNDS
06/20/2002WO2002024681A3 Pyrazine derivatives as modulators of tyrosine kinases
06/20/2002WO2002022074A3 Use of 2- and 4- quinolones for inhibiting intimal neo-proliferation
06/20/2002WO2002020495A3 Inhibitors of glycogen synthase kinase 3
06/20/2002WO2002020464A3 Benzene tricarboxylic acid amides as insulin receptor activators
06/20/2002WO2002020013A3 A method for treating allergies using substituted pyrazoles
06/20/2002WO2002016312A3 NOVEL COMPOUNDS INHIBITING FACTOR Xa ACTIVITY
06/20/2002WO2002013766A3 Valproic acid derivatives for the treatment of pain
06/20/2002WO2002012243A3 SYNTHESIS OF (R)-3-(4-BROMOBENZYL)-1-(3,5-DICHLOROPHENYL)-5-IODO-3-METHYL-1-H-IMIDAZO[1,2-a]IMIDAZOL-2-ONE
06/20/2002WO2002012214A3 Non-imidazole aryloxyalkylamines as h3 receptor ligands
06/20/2002WO2002011732A8 Novel bicyclic and tricyclic pyrrolidine derivatives as gnrh antagonists
06/20/2002WO2002011719A3 Lipase inhibitors for the treatment of dyspepsia
06/20/2002WO2002008226A3 Tricyclic 2-pyridone compounds useful as hiv reverse transcriptase inhibitors
06/20/2002WO2002005800A8 Compositions for sustained release of analgesic agents, and methods of making and using the same
06/20/2002WO2002004455A3 4-phenyl substituted tetrahydroisoquinolines and therapeutic use thereof
06/20/2002WO2002004422A3 Heterocycle carboxamides as antiviral agents
06/20/2002WO2002002092A3 Compositions based on aminoacids, suitable for improving muscle performance
06/20/2002WO2002002087A3 Anthelminthic agents for the prevention of parasitic infections in humans and animals ii
06/20/2002WO2002002085A3 Rapidly-decomposing administrable form for releasing active ingredients in the oral cavity or in bodily cavities
06/20/2002WO2002000711A3 Ev-vegf nucleic acids and polypeptides and methods of use
06/20/2002WO2002000165A3 Agent for reversal of drug resistance in mycobacterium tuberculosis
06/20/2002WO2001098518A3 Biotransformation of biologically active compounds made of various classes of chemical substances by means of laccase and manganese peroxidase enzymes
06/20/2002WO2001097780A3 Pharmaceutical compositions comprising an opioid analgesic
06/20/2002WO2001094613A3 Methods and compounds for influencing beta3 integrin-dependent intracellular processes
06/20/2002WO2001090152A3 Compositions and methods for the therapy and diagnosis of breast cancer
06/20/2002WO2001089570A3 Combination of growth hormone secretagogues and antidepressants
06/20/2002WO2001087264A3 Rapidly disintegrating solid oral dosage form
06/20/2002WO2001085096A3 Mast cell regulation
06/20/2002WO2001083436A3 Small technetium-99m and rhenium labeled agents and methods for imaging tumors
06/20/2002WO2001080825A3 Sustained release drug delivery devices, methods of use, and methods of manufacturing thereof
06/20/2002WO2001078705A3 Compositions containing a naphthalmide and an antiproliferative agent
06/20/2002WO2001078699A3 Use of bradycardiac substances in the treatment of myocardial diseases associated with hypertrophy and novel medicament combinations
06/20/2002WO2001077164A3 Diagnosis of diseases associated with apoptosis by means of assessing the methylation status of genes associated with apoptosis
06/20/2002WO2001077113A3 Macrocyclic ns3-serine protease inhibitors of hepatitis c virus comprising n-cyclic p2 moieties
06/20/2002WO2001076576A3 A pharmaceutical composition for treatment of acute, chronic pain and/or neuropathic pain and migraines
1 ... 5787 5788 5789 5790 5791 5792 5793 5794 5795 5796 5797 5798 5799 5800 5801 5802 5803 5804 5805 5806 5807 ... 7860